LOCUS MICROBIAL SOLUTIONS
LOCUS MICROBIAL SOLUTIONS
Industry:
Biotechnology Pharmaceutical
Website Url:
http://www.locusmicrobes.com
Status:
Active
Technology used in webpage:
Amazon GoDaddy DNS AWS Global Accelerator GoDaddy Email
Similar Organizations
Agreen Biotech
Biotech company China
Raptamer Discovery Group
Biotechnology Company
Official Site Inspections
http://www.locusmicrobes.com
Unable to get host informations!!!
More informations about "Locus Microbial Solutions"
Locus Microbial Solutions - Crunchbase Company Profile & Funding
Locus Microbial Solutions is a biotech firm that creates solutions that outperform chemicals in a wide range of industries. It utilizes the power of microorganisms to create patented, biobased …See details»
Locus Microbial Solutions - Overview, News & Similar ... - ZoomInfo
View Locus Microbial Solutions (www.locusmicrobes.com) location , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Locus Biosciences - Wikipedia
Locus Biosciences is a clinical-stage pharmaceutical company, founded in 2015 and based in Research Triangle Park, North Carolina. Locus develops phage therapies based on CRISPR–Cas3 gene editing technology, as opposed to the more commonly used CRISPR-Cas9, delivered by engineered bacteriophages. The intended therapeutic targets are antibiotic-resistant bacterial infections. See details»
About Us - Locus Biosciences
Paul is the CEO & Co-founder of Locus Biosciences. With a career that spans manufacturing, research & development, information technology and corporate transformations, Paul brings a …See details»
Locus Biosciences - Crunchbase Company Profile & Funding
Locus Biosciences may be growing as evidenced by the substantial financial support it has received for its clinical trials. The Biomedical Advanced Research and Development Authority …See details»
Home | Locus Fermentation Solutions (Locus FS)
Locus FS, the biosurfactant company, develops award-winning green solutions customized to outperform chemicals and help solve profitability, sustainability and ESG challenges in global …See details»
Locus Biosciences - Contacts, Employees, Board Members
Organization. Locus Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 4. Number of …See details»
Platform - Locus Bioscience
A Decade In The Making. The LOCUS platform industrialized the development of precision, engineered bacteriophage therapies. As a precision therapy, our products are built to be …See details»
Locus Biosciences signs contract with CARB-X to advance $14 …
Morrisville, NC – November 10, 2020 – Locus Biosciences, a clinical-stage biopharmaceutical company, announced today that it has signed a contract with the global non-profit, Combating …See details»
Locus Biosciences Receives $23.9 Million Boost for Bacteriophage ...
Jan 24, 2024 The Centers for Disease Control and Prevention and the World Health Organization have flagged antibiotic-resistant E. coli as a critical public health threat, …See details»
Meet Locus Biosciences: A 2021 Facility of the Year Honorable
Oct 25, 2021 The Facility of the Year Award (FOYA) Honorable Mention category recognizes projects that did not win a specific category but were clearly successful projects that overcame …See details»
Locus Biosciences - Products, Competitors, Financials, Employees ...
Headquarters Location. 523 Davis Drive Suite 350. Morrisville, North Carolina, 27560, United States. 919-313-9648See details»
Biologicals - Locus Ag
Subscribe to the Vital Input E-Newsletter. Don't miss out on the biological industry's most Vital Input! Subscribe to one of Locus AG's monthly e-newsletters and receive exclusive industry …See details»
Locus Biosciences Announces First Patient Treated in the
Sep 13, 2022 Both the U.S. Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have identified antibiotic-resistant E. coli as an urgent and serious …See details»
BARDA backs Locus phage therapy for resistant E coli
Jan 2, 2025 BARDA has given $24 million to Locus Bio to support a mid-stage trial of bacteriophage therapy LBP-EC01 for resistant E coli infections.See details»
Locus Science
Whether you’re research, pharma, diagnostic, hospital or academic lab, we will help you onboard novel molecular paradigms to combat UTIs and antibiotic resistance. We bring extensive …See details»
BARDA and Locus in tie-up to tackle UTIs with phages
Oct 8, 2020 Both the US Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) have identified antibiotic-resistant E. coli as an urgent and serious public …See details»
Locus Biosciences Announces First Patient Treated in the …
Sep 13, 2022 Marks first randomized Phase 2/3 trial of CRISPR-enhanced bacteriophage precision medicineRESEARCH TRIANGLE PARK, N.C., Sept. 13, 2022 (GLOBE …See details»
The Microbe Institute
We want to partner with you if you are a dreamer, a business person, a leader, a team-member, a scientist, an amateur, an explorer, an idealist, a big thinker, a details-person, an organization, …See details»
Human Microbes - Stool donors for FMT and research
The trillions of microbes that live in our guts impact & regulate every aspect of human health & development. This ecosystem of microbes -- comprising thousands of species of bacteria, …See details»